论文部分内容阅读
作者报道在B超引导下经皮脾穿刺移植胚胎脾细胞治疗晚期肝癌26例。临床观察症状明显改善,免疫力提高,癌块缩小,AFP定量下降,延长自然生存期,平均生存时间为16.4月。作者介绍了操作方法并就该方法治疗肝癌的机理、移植部位及疗效等问题进行了讨论。
The authors reported the use of B-ultrasound-guided percutaneous splenic transplantation of embryonic spleen cells in the treatment of 26 patients with advanced liver cancer. Observed clinical symptoms were significantly improved, immunity was improved, cancer mass was reduced, AFP decreased quantitatively, and the natural survival period was prolonged. The average survival time was 16.4 months. The author introduced the method of operation and discussed the mechanism of the treatment of liver cancer, the site of transplantation and the efficacy of the method.